Prosthetic heart valve thrombosis is a serious complication with high mortality and morbidity The best treatment of PVT is controversial, although surgery and thrombolysis options have been available. In this randomized and multicenter study, the investigators compared thrombolytic therapy versus surgery for the treatment of patients with obstructive prosthetic valve thrombosis.
Age range
18 Years – 85 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Thrombolytic success
Timeframe: Up to 10 days
Non-fatal complications for thrombolytic therapy
Timeframe: Participants will be followed for the duration of hospital stay, an expected average of 3 weeks
Successful Surgery
Timeframe: Participants will be followed for the duration of hospital stay, an expected average of 3 weeks; and postoperative 3 months
Complications for surgery
Timeframe: Participants will be followed for the duration of hospital stay an expected average of 3 weeks; and postoperative 3 month
In hospital mortality
Timeframe: Participants will be followed for the duration of hospital stay, an expected average of 3 weeks